Medical cannabis and cannabinoids
Cure8 research brief
Why This Matters
Many people with IBD try marijuana to ease symptoms. This survey suggests users often report symptom relief, improved quality of life, and less opioid use, which are directly relevant to daily functioning and symptom management.
Who Should Pay Attention
Adult IBD patients exploring symptom-relief options, clinicians caring for IBD patients, and researchers studying cannabis use or patient-reported outcomes in IBD.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This abstract reports a survey of 108 IBD patients about marijuana use for symptom control. It found associations between frequency/reason for use and self-reported relief for symptoms such as nausea, arthralgia, and insomnia, plus perceived improvements in independence, employment, and quality of life; many respondents believed marijuana reduced opioid use.
The study is a single-center patient survey (REDCap) with self-reported outcomes. The findings describe patient perceptions and patterns rather than objective clinical measurements. Because this is an abstract-level source, Cure8 is summarizing the authors' reported results from the provided abstract rather than a full peer-reviewed article text.
The study may reflect local practices and self-selection bias and does not establish causality. If you are considering marijuana for IBD symptoms, discuss it with your clinician to review legal status, potential interactions with medications, dosing, and monitoring. This summary does not replace medical advice.
Keep In Mind
This is a single-center survey of self-reported experiences (abstract-level). Responses reflect perceptions and associations, not controlled trial evidence. Legal status, product variability, and potential drug interactions are important considerations.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationMedical cannabis and cannabinoids
AuthorsDaneshmand A, Yung K, Gao H +7 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJan 1, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based survey.
Patients with Crohn's reported more relapses and are more likely to see diet as a relapse trigger; nutritional therapy (including elemental diets) is used more often in Crohn's than UC in this Japanese sample. This...
Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis
Some people with ulcerative colitis seek complementary or herbal treatments. This review reports research on a modified Gegen Qinlian Decoction that the authors say may strengthen the gut barrier and reduce inflammation,...
Remission duration according to dietary adherence in paediatric mild to moderate Crohn's disease treated with CDED + PEN.
Dietary therapy (CDED + PEN) was associated with longer remission when families adhered well; since adherence varies, support from a dietitian matters for keeping children in remission.